Flagship explainer
How Elite Pharmaceuticals, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $149M | 100% |
| |
| Cost of revenue | $73.8M | 50% |
|
| $75M | 50% |
| |
| $49.1M | 33% |
| |
| Income before tax | $56.8M | 38% |
|
| Income tax | $11.9M | 8% |
|
| $44.9M | 30% |
|
Source:
- SEC filing · FY 2026Filing detailsAccession 0001493152-26-031070